Publication | Closed Access

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Breast OncologyMedicineBreast CancerTriple-negative Breast CancerFirst-line Subtyping-based TherapyCancer TreatmentOncologyRadiology